MONTREAL, QC / ACCESS Newswire / March 27, 2025 / Vision Marine Technologies Inc. (NASDAQ:VMAR), a pioneer in electric marine propulsion, today announced that the Company's board of directors (the ...

Nxu, Inc., (NASDAQ: NXU) (“Nxu”, “the Company”), a domestic technology company focused on energy storage and charging solutions for the infrastructure we need to power our electrified future, today ...

Auddia Inc., (“Auddia” or the “Company”) (NASDAQ: AUUD, AUUDW), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how ...

Holdings will effect a reverse stock split of its outstanding shares of common stock, par value $0.001 per share, at a ...

Auddia Inc., ("Auddia" or the "Company") (NASDAQ: AUUD, AUUDW), an AI first technology company that has built a proprietary AI platform for audio identification ...

Outset Medical, Inc. (Nasdaq: OM) ("Outset” or the "Company”), a medical technology company pioneering a first-of-its-kind ...

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary ...

Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) ("Virpax" or the "Company") a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous ...

Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD), today announced that it will effect ...

The Company's common stock is expected to begin trading on a split-adjusted basis when the market opens on March 18, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol ...

Organovo’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “ONVO” with a new CUSIP number of 68620A302. At the effective time of the reverse stock split ...